January 4, 2013 / 61(51);1038-1042
Screening women for cervical cancer can save lives. However, among young women, cervical cancer is relatively rare (1,2), and too-frequent screening can lead to high costs and adverse events associated with overtreatment (3). Before 2012, cervical cancer screening guidelines of the American College of Obstetricians and Gynecologists (ACOG), American Cancer Society (ACS), and U.S. Preventive Services Task Force (USPSTF) differed on age to start and how often to get screened for cervical cancer. (4). In ...
Written by National Institutes of Health: Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more than 45 percent of sexually active young women who have acquired HIV appear never to have been exposed to the most common high-risk forms of HPV, according to the study from a National Institutes of Health research network.
The European Research Organization on Genital Infection and Neoplasia (EUROGIN) recently produced a continuing medical education (CME) course for practitioners entitled “Human Papillomavirus (HPV)-related cancers and diseases.” The course focuses on HPV and related cancers as well as best practices for screening management and prevention efforts. The course is intended for gynecologists, pediatricians, and general practitioners and takes approximately one hour to complete. More information about the course, as well as how to access it, can be found
Written by ScienceDaily (Oct. 10, 2012) — A study published in Vaccine reveals that contrary to recent discussions, the HPV vaccination does not increase sexual activity in adolescent girls.
There have been claims recently that the HPV (Human papillomavirus) vaccination increases sexual activity in adolescent girls as it effectively gives them a ‘green light’ to have sex because of a perceived protection against sexually transmitted infections. This study examines whether or not there is any influence on sexual behaviour as a result ...
(NYTimes Health) In a small, preliminary study, an experimental vaccine provoked a strong immune response against precancerous cells in women treated for cervical lesions that can progress to cancer.
Most cases of cervical cancer are caused by infection with two types of human papillomavirus, or HPV. Some women ...
(Reuters Health) – A study of nearly 190,000 young women injected with Merck & Co’s human papillomavirus vaccine Gardasil found no new safety concerns.
Researchers said the only side effects they observed – rare cases of skin infections and fainting – were benign and expected.
“This analysis was very reassuring,” said lead researcher Dr. Nicola Klein of the Kaiser Permanente Vaccine Study Center in Oakland, California, whose work was funded by Merck.
HPV vaccination is recommended for both boys and girls to shield ...
New Rochelle, NY, August 7, 2012—Vaccination against human papilloma virus (HPV) is recommended for young women to protect them from HPV infection and cervical cancer. Male HPV immunization is increasingly a topic of debate in the medical community. A timely review of the literature published in Viral Immunology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, explores whether HPV vaccination of young men is warranted and cost effective. The article is available free online at the Viral Immunology website.
Gorren Low ...
The American Cancer Society Cancer Action Network (ACS CAN) has released a report on state-level policy progress and challenges from 2012. The report analyzes how state policy and funding affect cancer prevention and treatment in the United States.
According to the report, federal and state budget cuts are impacting the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a program providing breast and cervical cancer screening access and follow-up care to low-income women. In 2011, nearly half of ...
The United States House of Representatives has voted on a bill to repeal the Patient Protection and Affordable Care Act (ACA). The bill passed in the House by a vote of 244 to 185. The House has voted over 30 times to try to repeal ACA. This vote comes two weeks after the Supreme Court’s decision to largely uphold ACA.
The bill is not expected to be approved in the Senate.
The CDC’s Behavioral Risk Factor Surveillance Branch has released 2005-2010 BRFSS data. This data, accessible through CDC’s Web-Enabled Analysis Tool (WEAT), is available by state for 2005-2010.
The BRFSS provides data on health risk behaviors, clinical preventive health practices, and health care access across all 50 states, the District of Columbia, Puerto Rico, the Virgin Islands, and Guam. The WEAT BRFSS data are located here.